Effect of Dulaglutide and Long-Acting Insulin Combination Therapy in Patients with Type 2 Diabetes

Objective: In patients with diabetes, The use of GLP-1 receptor agonist expected to decreases the number of injections and improves blood glucose control. In this study, the effects were evaluated when changed from intensive insulin therapy to combination therapy of long-acting GLP-1 receptor agonist, duraglutide, and long-acting insulin. Methods: We examined patients with type 2 diabetes who were admitted to our department and started blood...